NHS Pharmacy First, launched in England on 31 January 2024, enables community pharmacies to complete episodes of care for seven common conditions under defined clinical pathways — acute otitis media, impetigo, infected insect bites, shingles, sinusitis, sore throat, and uncomplicated UTIs in women aged 16-64. NHS England describes the service as building on the Community Pharmacist Consultation Service and enabling community pharmacies to offer advice and supply NHS medicines, where clinically appropriate, without a GP prescription.
This service has fundamentally changed clinical expectations. Community pharmacists now assess presenting symptoms, check for red flags, apply structured clinical pathways, make treatment decisions, supply medicines under Patient Group Directions, provide counselling, safety-net, and document the episode of care. The expanded clinical role creates demand for fast, reliable clinical decision support at the point of care.
Where AI Can Help in Pharmacy First Consultations
Symptom structuring. When a patient presents with sore throat, the pharmacist needs to systematically assess: duration, severity, associated features (fever, rash, lymphadenopathy), red flags (trismus, peritonsillar swelling, drooling, voice change, respiratory difficulty), and Centor/FeverPAIN criteria where relevant. AI can prompt this systematic assessment — particularly useful for pharmacists early in their Pharmacy First experience or encountering presentations they manage less frequently.
Red flag prompts. For each Pharmacy First condition, there are specific red flags that should prompt referral rather than pharmacy management. For sore throat: peritonsillar abscess signs, stridor, severe dehydration, immunosuppression. For UTI: fever, loin pain, haematuria, pregnancy, male patient, recurrent infections, catheterised patient. For shingles: ophthalmic involvement, immunosuppression, disseminated disease. AI can help the pharmacist systematically check all relevant red flags — reducing the risk of missed serious pathology.
Counselling points. Once a medicine is selected under the PGD, AI can structure comprehensive counselling: administration advice, expected time to improvement, common side effects, serious warnings, when to return to the pharmacy, and when to seek emergency help. This is particularly valuable for medicines supplied less frequently.
Medicine safety checks. Before supplying, the pharmacist must confirm the medicine is appropriate for this specific patient — allergies (including cross-reactivity), interactions with current medications, contraindications (pregnancy, breastfeeding, specific comorbidities), age restrictions, and renal/hepatic dose considerations. AI with SmPC-grounded information can support this systematic checking.
Patient-friendly explanations. Translating clinical reasoning into plain language — why this specific medicine was chosen, what the condition is, what to expect during recovery, and specifically what symptoms should trigger re-presentation.
Where AI Must Be Checked by the Pharmacist
PGD eligibility and exclusions. The clinical pathway defines precise inclusion and exclusion criteria. The pharmacist must verify eligibility — AI cannot confirm PGD compliance from a conversation alone. Pregnancy, severe symptoms, immunosuppression, age restrictions, and specific comorbidities may exclude a patient.
Antimicrobial stewardship. Pharmacy First pathways for UTI and impetigo include specific antibiotic choices aligned with antimicrobial stewardship requirements. The pharmacist should verify that the selection aligns with both the national pathway and any local stewardship variations — particularly antibiotic choice and duration.
When to refer. Red flags, treatment failure, diagnostic uncertainty, and presentations that fall outside the pathway scope should prompt referral. The pharmacist's clinical judgement determines when pharmacy management is no longer appropriate.
Why SmPC-Powered Information Matters
When supplying a medicine under Pharmacy First, the pharmacist's counselling and safety checking should be grounded in the UK-licensed SmPC — the authoritative product information. Ask iatroX provides medicines information powered via eMC/SmPC, supporting clinical reasoning with regulated source data.
For Exam Candidates
Pharmacy First-style scenarios are directly CRA-relevant. The iatroX premium pharmacist Q-bank includes applied scenarios testing symptom assessment, red flag identification, medicine selection, and counselling — the same judgement expected in practice.
Use Ask iatroX for clinical reasoning in practice; the premium Q-bank for applied exam scenarios →